Sand-fly saliva-Leishmania-man: The trigger trio

Frontiers in Immunology

Volumn 4, Issue NOV, 2013, Pages

  Oliveira, Fabiano ^a   de Carvalho, Augusto M ^b   de Oliveira, Camila I ^b,c  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c Instituto Nacional de Ciencia e Tecnologia de Investigacao em Imunologia iii INCT   (Brazil)

Author keywords

Leishmania; Leishmaniasis; Saliva; Sand fly; Vaccine

Indexed keywords

FAS LIGAND; GAMMA INTERFERON; HYALURONIDASE; IMMUNOGLOBULIN G; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOTRIENE B4; MAXADILAN; PROSTAGLANDIN E2; THROMBOXANE A2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; DELAYED HYPERSENSITIVITY; DIPTERA; DISEASE SEVERITY; DISEASE TRANSMISSION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; LEISHMANIASIS; LUTZOMYIA; NONHUMAN; OUTCOME ASSESSMENT; PARASITE LOAD; PARASITE SURVIVAL; PHLEBOTOMUS; PROTEIN EXPRESSION; SALIVA; SHORT SURVEY; VACCINATION;

EID: 84890392430     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00375     Document Type: Short Survey

References (93)

1. Ribeiro JM. Role of saliva in blood-feeding by arthropods. Annu Rev Entomol (1987) 32:463-78. doi: 10.1146/annurev.en.32.010187.002335
2. Titus RG, Ribeiro JM. Salivary gland lysates from the sand fly Lutzomyia longipalpis enhance Leishmania infectivity. Science (1988) 239:1306-8. doi:10.1126/science.3344436
3. Theodos C, Ribeiro J, Titus R. Analysis of enhancing effect of sand fly saliva on Leishmania infection in mice. Infect Immun (1991) 59:1592-8.
4. Anjili CO, Mbati PA, Mwangi RW, Githure JI, Olobo JO, Robert LL, et al. The chemotactic effect of Phlebotomus duboscqi (diptera: psychodidae) salivary gland lysates to murine monocytes. Acta Trop (1995) 60:97-100. doi:10.1016/0001-706X(95)00112-R
5. Hall LR, Titus RG. Sand fly vector saliva selectively modulates macrophage functions that inhibit killing of Leishmania major and nitric oxide production. J Immunol (1995) 155:3501-6.
6. Waitumbi J, Warburg A. Phlebotomus papatasi saliva inhibits protein phosphatase activity and nitric oxide production by murine macrophages. Infect Immun (1998) 66:1534-7.
7. Belkaid Y, Kamhawi S, Modi G, Valenzuela J, Noben-Trauth N, Rowton E, et al. Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis. J Exp Med (1998) 188:1941-53. doi:10.1084/jem.188.10.1941
8. Mbow ML, Bleyenberg JA, Hall LR, Titus RG. Phlebotomus papatasi sand fly salivary gland lysate down-regulates a Th1, but up-regulates a Th2, response in mice infected with Leishmania major. J Immunol (1998) 161:5571-7.
9. Norsworthy N, Sun J, Elnaiem D, Lanzaro G, Soong L. Sand fly saliva enhances Leishmania amazonensis infection by modulating interleukin-10 production. Infect Immun (2004) 72:1240-7. doi:10.1128/IAI.72.3.1240-1247.2004
10. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol (2001) 19:683-765. doi:10.1146/annurev.immunol.19.1.683
11. Zer R, Yaroslavski I, Rosen L, Warburg A. Effect of sand fly saliva on Leishmania uptake by murine macrophages. Int J Parasitol (2001) 31:810-4. doi:10.1016/S0020-7519(01)00190-4
12. Teixeira C, Teixeira M, Gomes R, Santos C, Andrade B, Raffaele-Netto I, et al. Saliva from Lutzomyia longipalpis induces CC chemokine ligand 2/monocyte chemoattractant protein-1 expression and macrophage recruitment 1. J Immunol (2005) 175:8346-53.
13. Silva F, Gomes R, Prates D, Miranda JC, Andrade B, Barral-Netto M, et al. Inflammatory cell infiltration and high antibody production in BALB/c mice caused by natural exposure to Lutzomyia longipalpis bites. Am J Trop Med Hyg (2005) 72:94-8.
14. Monteiro MC, Lima HC, Souza AA, Titus RG, Romao PR, Cunha FQ. Effect of Lutzomyia longipalpis salivary gland extracts on leukocyte migration induced by Leishmania major. Am J Trop Med Hyg (2007) 76:88-94.
15. Monteiro MC, Nogueira LG, Almeida Souza AA, Ribeiro JM, Silva JS, Cunha FQ. Effect of salivary gland extract of Leishmania vector, Lutzomyia longipalpis, on leukocyte migration in OVA-induced immune peritonitis. Eur J Immunol (2005) 35:2424-33. doi:10.1002/eji.200526160
16. Carregaro V, Valenzuela JG, Cunha TM, Verri WA Jr, Grespan R, Matsumura G, et al. Phlebotomine salivas inhibit immune inflammation-induced neutrophil migration via an autocrine DC-derived PGE2/IL-10 sequential pathway. J Leukoc Biol (2008) 84:104-14. doi:10.1189/jlb.1107797
17. Araujo-Santos T, Prates DB, Andrade BB, Nascimento DO, Clarencio J, Entringer PF, et al. Lutzomyia longipalpis saliva triggers lipid body formation and prostaglandin E(2) production in murine macrophages. PLoS Negl Trop Dis (2010) 4:e873. doi:10.1371/journal.pntd.0000873
18. Lonardoni MV, Barbieri CL, Russo M, Jancar S. Modulation of Leishmania (L.) amazonensis growth in cultured mouse macrophages by prostaglandins and platelet activating factor. Mediators Inflamm (1994) 3:137-41. doi:10.1155/S0962935194000177
19. Prates DB, Araújo-Santos T, Luz NF, Andrade BB, França-Costa J, Afonso L, et al. Lutzomyia longipalpis saliva drives apoptosis and enhances parasite burden in neutrophils. J Leukoc Biol (2011) 90(3):575-82. doi:10.1189/jlb.0211105
20. Ribeiro JM. Vector saliva and its role in parasite transmission. Exp Parasitol (1989) 69:104-6. doi:10.1016/0014-4894(89)90177-X
21. Lerner EA, Ribeiro JM, Nelson RJ, Lerner MR. Isolation of maxadilan, a potent vasodilatory peptide from the salivary glands of the sand fly Lutzomyia longipalpis. J Biol Chem (1991) 266:11234-6.
22. Qureshi AA, Asahina A, Ohnuma M, Tajima M, Granstein RD, Lerner EA. Immunomodulatory properties of maxadilan, the vasodilator peptide from sand fly salivary gland extracts. Am J Trop Med Hyg (1996) 54:665-71.
23. Bozza M, Soares MB, Bozza PT, Satoskar AR, Diacovo TG, Brombacher F, et al. The PACAP-type I receptor agonist maxadilan from sand fly saliva protects mice against lethal endotoxemia by a mechanism partially dependent on IL-10. Eur J Immunol (1998) 28:3120-7. doi:10.1002/(SICI)1521-4141(199810)28:10<3120::AID-IMMU3120>3.0.CO;2-3
24. Soares MB, Titus RG, Shoemaker CB, David JR, Bozza M. The vasoactive peptide maxadilan from sand fly saliva inhibits TNF-alpha and induces IL-6 by mouse macrophages through interaction with the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor. J Immunol (1998) 160:1811-6.
25. Morris RV, Shoemaker CB, David JR, Lanzaro GC, Titus RG. Sandfly maxadilan exacerbates infection with Leishmania major and vaccinating against it protects against L. major infection. J Immunol (2001) 167:5226-30.
26. Brodie T, Smith M, Morris R, Titus R. Immunomodulatory effects of the Lutzomyia longipalpis salivary gland protein maxadilan on mouse macrophages. Infect Immun (2007) 75:2359-65. doi:10.1128/IAI.01812-06
27. Carregaro V, Sa-Nunes A, Cunha TM, Grespan R, Oliveira CJ, Lima-Junior DS, et al. Nucleosides from Phlebotomus papatasi salivary gland ameliorate murine collagen-induced arthritis by impairing dendritic cell functions. J Immunol (2011) 187:4347-59. doi:10.4049/jimmunol.1003404
28. Ribeiro JM, Katz O, Pannell LK, Waitumbi J, Warburg A. Salivary glands of the sand fly Phlebotomus papatasi contain pharmacologically active amounts of adenosine and 5'-AMP. J Exp Biol (1999) 202:1551-9.
29. Grespan R, Lemos HP, Carregaro V, Verri WA Jr, Souto FO, de Oliveira CJ, et al. The protein LJM 111 from Lutzomyia longipalpis salivary gland extract (SGE) accounts for the SGE-inhibitory effects upon inflammatory parameters in experimental arthritis model. Int Immunopharmacol (2012) 12:603-10. doi:10.1016/j.intimp.2012.02.004
30. Rogers KA, Titus RG. Immunomodulatory effects of maxadilan and Phlebotomus papatasi sand fly salivary gland lysates on human primary in vitro immune responses. Parasite Immunol (2003) 25:127-34. doi:10.1046/j.1365-3024.2003.00623.x
31. Costa DJ, Favali C, Clarencio J, Afonso L, Conceicao V, Miranda JC, et al. Lutzomyia longipalpis salivary gland homogenate impairs cytokine production and costimulatory molecule expression on human monocytes and dendritic cells. Infect Immun (2004) 72:1298-305. doi:10.1128/IAI.72.3.1298-1305.2004
32. Kamhawi S. Protection against cutaneous leishmaniasis resulting from bites of uninfected sand flies. Science (2000) 290:1351-4. doi:10.1126/science.290.5495.1351
33. Valenzuela JG, Belkaid Y, Garfield MK, Mendez S, Kamhawi S, Rowton ED, et al. Toward a defined anti-Leishmania vaccine targeting vector antigens: characterization of a protective salivary protein. J Exp Med (2001) 194:331-42. doi:10.1084/jem.194.3.331
34. Gomes R, Teixeira C, Teixeira MJ, Oliveira F, Menezes MJ, Silva C, et al. Immunity to a salivary protein of a sand fly vector protects against the fatal outcome of visceral leishmaniasis in a hamster model. Proc Natl Acad Sci U S A (2008) 105:7845-50. doi:10.1073/pnas.0712153105
35. Collin N, Gomes R, Teixeira C, Cheng L, Laughinghouse A, Ward JM, et al. Sand fly salivary proteins induce strong cellular immunity in a natural reservoir of visceral leishmaniasis with adverse consequences for Leishmania. PLoS Pathog (2009) 5:e1000441. doi:10.1371/journal.ppat.1000441
36. Gomes R, Oliveira F, Teixeira C, Meneses C, Gilmore DC, Elnaiem DE, et al. Immunity to sand fly salivary protein LJM11 modulates host response to vector-transmitted Leishmania conferring ulcer-free protection. J Invest Dermatol (2012) 132:2735-43. doi:10.1038/jid.2012.205
37. Basu R, Bhaumik S, Basu JM, Naskar K, De T, Roy S. Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and-resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for mixed Th1-and Th2-like responses in visceral leishmaniasis. J Immunol (2005) 174:7160-71.
38. da Silva RA, Tavares NM, Costa D, Pitombo M, Barbosa L, Fukutani K, et al. DNA vaccination with KMP11 and Lutzomyia longipalpis salivary protein protects hamsters against visceral leishmaniasis. Acta Trop (2011) 120:185-90. doi:10.1016/j.actatropica.2011.08.007
39. Tavares NM, Silva RA, Costa DJ, Pitombo MA, Fukutani KF, Miranda JC, et al. Lutzomyia longipalpis saliva or salivary protein LJM19 protects against Leishmania braziliensis and the saliva of its vector, Lutzomyia intermedia. PLoS Negl Trop Dis (2011) 5:e1169. doi:10.1371/journal.pntd.0001169
40. Carregaro V, Costa DL, Brodskyn C, Barral AM, Barral-Netto M, Cunha FQ, et al. Dual effect of Lutzomyia longipalpis saliva on Leishmania braziliensis infection is mediated by distinct saliva-induced cellular recruitment into BALB/c mice ear. BMC Microbiol (2013) 13:102. doi:10.1186/1471-2180-13-102
41. Gomes R, Oliveira F. The immune response to sand fly salivary proteins and its influence on Leishmania immunity. Front Immunol (2012) 3:110. doi:10.3389/fimmu.2012.00110
42. Peters N, Egen J, Secundino N, Debrabant A, Kimblin N, Kamhawi S, et al. In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies. Science (2008) 321:970-4. doi:10.1126/science.1159194
43. Goto Y, Bhatia A, Raman VS, Liang H, Mohamath R, Picone AF, et al. KSAC, the first defined polyprotein vaccine candidate for visceral leishmaniasis. Clin Vaccine Immunol (2011) 18:1118-24. doi:10.1128/CVI.05024-11
44. Bertholet S, Goto Y, Carter L, Bhatia A, Howard RF, Carter D, et al. Optimized subunit vaccine protects against experimental leishmaniasis. Vaccine (2009) 27:7036-45. doi:10.1016/j.vaccine.2009.09.066
45. Gomes R, Teixeira C, Oliveira F, Lawyer PG, Elnaiem DE, Meneses C, et al. KSAC, a defined Leishmania antigen, plus adjuvant protects against the virulence of L. major transmitted by its natural vector Phlebotomus duboscqi. PLoS Negl Trop Dis (2012) 6:e1610. doi:10.1371/journal.pntd.0001610
46. Daifalla NS, Bayih AG, Gedamu L. Leishmania donovani recombinant iron superoxide dismutase B1 protein in the presence of TLR-based adjuvants induces partial protection of BALB/c mice against Leishmania major infection. Exp Parasitol (2012) 131:317-24. doi:10.1016/j.exppara.2012.05.002
47. Peters NC, Bertholet S, Lawyer PG, Charmoy M, Romano A, Ribeiro-Gomes FL, et al. Evaluation of recombinant Leishmania polyprotein plus glucopyranosyl lipid A stable emulsion vaccines against sand fly-transmitted Leishmania major in C57BL/6 mice. J Immunol (2012) 189:4832-41. doi:10.4049/jimmunol.1201676
48. Peters NC, Kimblin N, Secundino N, Kamhawi S, Lawyer P, Sacks DL. Vector transmission of Leishmania abrogates vaccine-induced protective immunity. PLoS Pathog (2009) 5:e1000484. doi:10.1371/journal.ppat.1000484
49. Samuelson J, Lerner E, Tesh R, Titus R. A mouse model of Leishmania braziliensis braziliensis infection produced by coinjection with sand fly saliva. J Exp Med (1991) 173:49-54. doi:10.1084/jem.173.1.49
50. Lima H, Titus R. Effects of sand fly vector saliva on development of cutaneous lesions and the immune response to Leishmania braziliensis in BALB/c mice. Infect Immun (1996) 64:5442.
51. Donnelly KB, Lima HC, Titus RG. Histologic characterization of experimental cutaneous leishmaniasis in mice infected with Leishmania braziliensis in the presence or absence of sand fly vector salivary gland lysate. J Parasitol (1998) 84:97-103. doi:10.2307/3284537
52. Bezerra H, Teixeira M. Effect of Lutzomyia whitmani (diptera: psychodidae) salivary gland lysates on Leishmania (Viannia) braziliensis infection in BALB/c mice. Mem Inst Oswaldo Cruz (2001) 96:349-51. doi:10.1590/S0074-02762001000300011
53. de Moura TR, Oliveira F, Novais FO, Miranda JC, Clarencio J, Follador I, et al. Enhanced Leishmania braziliensis infection following pre-exposure to sandfly saliva. PLoS Negl Trop Dis (2007) 1:e84. doi:10.1371/journal.pntd.0000084
54. Menezes MJ, Costa DJ, Clarencio J, Miranda JC, Barral A, Barral-Netto M, et al. Immunomodulation of human monocytes following exposure to Lutzomyia intermedia saliva. BMC Immunol (2008) 9:12. doi:10.1186/1471-2172-9-12
55. Oliveira F, Lawyer PG, Kamhawi S, Valenzuela JG. Immunity to distinct sand fly salivary proteins primes the anti-Leishmania immune response towards protection or exacerbation of disease. PLoS Negl Trop Dis (2008) 2:e226. doi:10.1371/journal.pntd.0000226
56. Ribeiro JM, Sarkis JJ, Rossignol PA, Spielman A. Salivary apyrase of Aedes aegypti: characterization and secretory fate. Comp Biochem Physiol B (1984) 79:81-6.
57. Sarkis JJ, Guimaraes JA, Ribeiro JM. Salivary apyrase of Rhodnius prolixus. Kinetics and purification. Biochem J (1986) 233:885-91.
58. Ribeiro JM, Vaughan JA, Azad AF. Characterization of the salivary apyrase activity of three rodent flea species. Comp Biochem Physiol B (1990) 95:215-9.
59. Ribeiro JM, Endris TM, Endris R. Saliva of the soft tick, Ornithodoros moubata, contains anti-platelet and apyrase activities. Comp Biochem Physiol A Comp Physiol (1991) 100:109-12. doi:10.1016/0300-9629(91)90190-N
60. Champagne DE, Smartt CT, Ribeiro JM, James AA. The salivary gland-specific apyrase of the mosquito Aedes aegypti is a member of the 5'-nucleotidase family. Proc Natl Acad Sci U S A (1995) 92:694-8. doi:10.1073/pnas.92.3.694
61. Mathews GV, Sidjanski S, Vanderberg JP. Inhibition of mosquito salivary gland apyrase activity by antibodies produced in mice immunized by bites of Anopheles stephensi mosquitoes. Am J Trop Med Hyg (1996) 55:417-23.
62. Mans BJ, Gaspar AR, Louw AI, Neitz AW. Apyrase activity and platelet aggregation inhibitors in the tick Ornithodoros savignyi (Acari: Argasidae). Exp Appl Acarol (1998) 22:353-66. doi:10.1023/A:1024517209621
63. Lombardo F, Di Cristina M, Spanos L, Louis C, Coluzzi M, Arca B. Promoter sequences of the putative Anopheles gambiae apyrase confer salivary gland expression in Drosophila melanogaster. J Biol Chem (2000) 275:23861-8. doi:10.1074/jbc.M909547199
64. Valenzuela JG, Belkaid Y, Rowton E, Ribeiro JM. The salivary apyrase of the blood-sucking sand fly Phlebotomus papatasi belongs to the novel Cimex family of apyrases. J Exp Biol (2001) 204:229-37.
65. Reno HE, Novak RJ. Characterization of apyrase-like activity in Ochlerotatus triseriatus, Ochlerotatus hendersoni, and Aedes aegypti. Am J Trop Med Hyg (2005) 73:541-5.
66. Calvo E, Ribeiro JM. A novel secreted endonuclease from Culex quinquefasciatus salivary glands. J Exp Biol (2006) 209:2651-9. doi:10.1242/jeb.02267
67. Calvo E, Mans BJ, Ribeiro JM, Andersen JF. Multifunctionality and mechanism of ligand binding in a mosquito antiinflammatory protein. Proc Natl Acad Sci U S A (2009) 106:3728-33. doi:10.1073/pnas.0813190106
68. Alvarenga PH, Francischetti IM, Calvo E, Sa-Nunes A, Ribeiro JM, Andersen JF. The function and three-dimensional structure of a thromboxane A2/cysteinyl leukotriene-binding protein from the saliva of a mosquito vector of the malaria parasite. PLoS Biol (2010) 8:e1000547. doi:10.1371/journal.pbio.1000547
69. Xu X, Oliveira F, Chang BW, Collin N, Gomes R, Teixeira C, et al. Structure and function of a "yellow" protein from saliva of the sand fly Lutzomyia longipalpis that confers protective immunity against Leishmania major infection. J Biol Chem (2011) 286:32383-93. doi:10.1074/jbc.M111.268904
70. Collin N, Assumpcao TC, Mizurini DM, Gilmore DC, Dutra-Oliveira A, Kotsyfakis M, et al. Lufaxin, a novel factor Xa inhibitor from the salivary gland of the sand fly Lutzomyia longipalpis blocks protease-activated receptor 2 activation and inhibits inflammation and thrombosis in vivo. Arterioscler Thromb Vasc Biol (2012) 32:2185-98. doi:10.1161/ATVBAHA.112.253906
71. Anderson JM, Oliveira F, Kamhawi S, Mans BJ, Reynoso D, Seitz AE, et al. Comparative salivary gland transcriptomics of sandfly vectors of visceral leishmaniasis. BMC Genomics (2006) 7:52. doi:10.1186/1471-2164-7-52
72. Ribeiro JM, Mans BJ, Arca B. An insight into the sialome of blood-feeding Nematocera. Insect Biochem Mol Biol (2010) 40:767-84. doi:10.1016/j.ibmb.2010.08.002
73. de Moura TR, Oliveira F, Carneiro MW, Miranda JC, Clarencio J, Barral-Netto M, et al. Functional transcriptomics of wild-caught Lutzomyia intermedia salivary glands: identification of a protective salivary protein against Leishmania braziliensis infection. PLoS Negl Trop Dis (2013) 7:e2242. doi:10.1371/journal.pntd.0002242
74. Kato H, Jochim RC, Gomez EA, Uezato H, Mimori T, Korenaga M, et al. Analysis of salivary gland transcripts of the sand fly Lutzomyia ayacuchensis, a vector of Andean-type cutaneous leishmaniasis. Infect Genet Evol (2013) 13:56-66. doi:10.1016/j.meegid.2012.08.024
75. Valenzuela JG, Garfield M, Rowton ED, Pham VM. Identification of the most abundant secreted proteins from the salivary glands of the sand fly Lutzomyia longipalpis, vector of Leishmania chagasi. J Exp Biol (2004) 207:3717-29. doi:10.1242/jeb.01185
76. Hostomska J, Volfova V, Mu J, Garfield M, Rohousova I, Volf P, et al. Analysis of salivary transcripts and antigens of the sand fly Phlebotomus arabicus. BMC Genomics (2009) 10:282. doi:10.1186/1471-2164-10-282
77. Abdeladhim M, Jochim RC, Ben Ahmed M, Zhioua E, Chelbi I, Cherni S, et al. Updating the salivary gland transcriptome of Phlebotomus papatasi (Tunisian strain): the search for sand fly-secreted immunogenic proteins for humans. PLoS One (2012) 7:e47347. doi:10.1371/journal.pone.0047347
78. Rohousova I, Subrahmanyam S, Volfova V, Mu J, Volf P, Valenzuela JG, et al. Salivary gland transcriptomes and proteomes of Phlebotomus tobbi and Phlebotomus sergenti, vectors of leishmaniasis. PLoS Negl Trop Dis (2012) 6:e1660. doi:10.1371/journal.pntd.0001660
79. Petersen TN, Brunak S, Von Heijne G, Nielsen H. SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat Methods (2011) 8:785-6. doi:10.1038/nmeth.1701
80. Barral A, Honda E, Caldas A, Costa J, Vinhas V, Rowton ED, et al. Human immune response to sand fly salivary gland antigens: a useful epidemiological marker? Am J Trop Med Hyg (2000) 62:740-5.
81. Gomes RB, Brodskyn C, de Oliveira CI, Costa J, Miranda JC, Caldas A, et al. Seroconversion against Lutzomyia longipalpis saliva concurrent with the development of anti-Leishmania chagasi delayed-type hypersensitivity. J Infect Dis (2002) 186:1530-4. doi:10.1086/344733
82. Vinhas V, Andrade BB, Paes F, Bomura A, Clarencio J, Miranda JC, et al. Human anti-saliva immune response following experimental exposure to the visceral leishmaniasis vector, Lutzomyia longipalpis. Eur J Immunol (2007) 37:3111-21. doi:10.1002/eji.200737431
83. Aquino DM, Caldas AJ, Miranda JC, Silva AA, Barral-Netto M, Barral A. Epidemiological study of the association between anti-Lutzomyia longipalpis saliva antibodies and development of delayed-type hypersensitivity to Leishmania antigen. Am J Trop Med Hyg (2010) 83(4):825-7. doi:10.4269/ajtmh.2010.10-0182
84. Teixeira C, Gomes R, Collin N, Reynoso D, Jochim R, Oliveira F, et al. Discovery of markers of exposure specific to bites of Lutzomyia longipalpis, the vector of Leishmania infantum chagasi in Latin America. PLoS Negl Trop Dis (2010) 4:e638. doi:10.1371/journal.pntd.0000638
85. Souza AP, Andrade BB, Aquino D, Entringer P, Miranda JC, Alcantara R, et al. Using recombinant proteins from Lutzomyia longipalpis saliva to estimate human vector exposure in visceral leishmaniasis endemic areas. PLoS Negl Trop Dis (2010) 4:e649. doi:10.1371/journal.pntd.0000649
86. Marzouki S, Ben Ahmed M, Boussoffara T, Abdeladhim M, Ben Aleya-Bouafif N, Namane A, et al. Characterization of the antibody response to the saliva of Phlebotomus papatasi in people living in endemic areas of cutaneous leishmaniasis. Am J Trop Med Hyg (2011) 84:653-61. doi:10.4269/ajtmh.2011.10-0598
87. Marzouki S, Abdeladhim M, Abdessalem CB, Oliveira F, Ferjani B, Gilmore D, et al. Salivary antigen SP32 is the immunodominant target of the antibody response to Phlebotomus papatasi bites in humans. PLoS Negl Trop Dis (2012) 6:e1911. doi:10.1371/journal.pntd.0001911
88. Rohousova I, Ozensoy S, Ozbel Y, Volf P. Detection of species-specific antibody response of humans and mice bitten by sand flies. Parasitology (2005) 130:493-9. doi:10.1017/S003118200400681X
89. Clements MF, Gidwani K, Kumar R, Hostomska J, Dinesh DS, Kumar V, et al. Measurement of recent exposure to Phlebotomus argentipes, the vector of Indian visceral leishmaniasis, by using human antibody responses to sand fly saliva. Am J Trop Med Hyg (2010) 82:801-7. doi:10.4269/ajtmh.2010.09-0336
90. Soares BR, Souza AP, Prates DB, de Oliveira CI, Barral-Netto M, Miranda JC, et al. Seroconversion of sentinel chickens as a biomarker for monitoring exposure to visceral leishmaniasis. Sci Rep (2013) 3:2352. doi:10.1038/srep02352
91. Oliveira F, Traore B, Gomes R, Faye O, Gilmore DC, Keita S, et al. Delayed-type hypersensitivity to sand fly saliva in humans from a leishmaniasis-endemic area of Mali is Th1-mediated and persists to midlife. J Invest Dermatol (2013) 133:452-9. doi:10.1038/jid.2012.315
92. Sacks D, Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol (2002) 2:845-58. doi:10.1038/nri933
93. Abdeladhim M, Ben Ahmed M, Marzouki S, Belhadj Hmida N, Boussoffara T, Belhaj Hamida N, et al. Human cellular immune response to the saliva of Phlebotomus papatasi is mediated by IL-10-producing CD8+ T cells and Th1-polarized CD4+ lymphocytes. PLoS Negl Trop Dis (2011) 5:e1345. doi:10.1371/journal.pntd.0001345